Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Trace Elem Med Biol ; 62: 126575, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32580100

RESUMEN

BACKGROUND: KIO3 and KI are the most common salt iodization agents. Coincidentally, iodine exists naturally in high-iodine drinking water in the form of iodide (I-) or iodate (IO3-). As an oxidizing substance, IO3- should be reduced to I- before it can be effectively used by the thyroid. However, there is a lack of systematic studies on the metabolic process of high dose KIO3in vivo. METHODS: The iodine metabolism processes in the thyroid and serum of rats after high KIO3 intake were determined using high-performance liquid chromatography-inductively coupled plasma-mass spectrometry (HPLC/ICP-MS) and arsenic cerium catalytic spectrophotometry. The changes of redox activity in the serum, thyroid, liver, and kidneys were observed by detecting total antioxidative activity (TAA). RESULTS: High doses of IO3- were completely reduced to I-in vivo within 0.5 h. The level of organic bound iodine in the serum was stable, while the organic bound iodine in the thyroid increased to a plateau after intake of high-dose KIO3. The levels of total iodine and I- in serum and thyroid increased quickly, then all decreased after reaching the maximum absorption peak, and I- had two absorption peaks in serum. The thyroid blocking dose of I- was 0.5 mg/kg in rat. Additionally, high KIO3 intake did not influence the TAA in serum and other tissues. CONCLUSION: The body is able to reduce and utilize high doses of KIO3 ingested through the digestive tract. The metabolism of high KIO3in vivo is characterized by two absorption process of I- in serum and the thyroid blocking effect. Moreover, a single intake of high-dose KIO3 does not affect TAA in vivo. The results suggest that such excess IO3- may have be reduced in the digestive tract before I- enters the blood.


Asunto(s)
Antioxidantes/metabolismo , Yodatos/farmacología , Yodo/metabolismo , Compuestos de Potasio/farmacología , Animales , Femenino , Yodatos/administración & dosificación , Yodatos/análisis , Yodatos/sangre , Yodatos/farmacocinética , Yodo/sangre , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Compuestos de Potasio/administración & dosificación , Compuestos de Potasio/farmacocinética , Ratas Wistar , Glándula Tiroides/efectos de los fármacos , Glándula Tiroides/metabolismo
2.
Recenti Prog Med ; 104(7-8): 406-8, 2013.
Artículo en Italiano | MEDLINE | ID: mdl-24042417

RESUMEN

In the study of urinary tract, traditional imaging modalities still play a vital role in the diagnosis of urothelial tumors of the upper urinary tract; however, the introduction of multidetector computed tomography has greatly changed the way of evaluation of urological patients. In fact, by means of a multiphasic study protocol is possible to recognize with high sensitivity small urothelial lesions and, moreover, to perform at the same time, an evaluation of local and metastatic extension also. The evaluation of the pattern of contrast enhancement in addition, allows a judgement of biological aggressiveness related to tumor grading.


Asunto(s)
Carcinoma de Células Transicionales/diagnóstico por imagen , Medios de Contraste , Yodatos , Tomografía Computarizada Multidetector/métodos , Urografía/métodos , Neoplasias Urológicas/diagnóstico por imagen , Anciano , Anciano de 80 o más Años , Carcinoma de Células Transicionales/patología , Protocolos Clínicos , Medios de Contraste/farmacocinética , Diuresis/efectos de los fármacos , Diuréticos/farmacología , Femenino , Furosemida/farmacología , Humanos , Yodatos/farmacocinética , Masculino , Persona de Mediana Edad , Clasificación del Tumor/métodos , Carga Tumoral , Neoplasias Urológicas/patología
3.
Biol Trace Elem Res ; 146(2): 262-71, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22038267

RESUMEN

Adsorption-desorption of iodine in two forms, viz., iodide (I(-)) and iodate (IO (3) (-) ), in three types of soil were investigated. The soils were: red soil developed on Quaternary red earths (REQ)- clayey, kaolintic thermic plinthite Aquult, Inceptisol soil (IS) and alluvial soil (AS)-Fluvio-marine yellow loamy soil. The isothermal curves of iodine adsorption on soils were described by Langmuir and Freundlich equation, and the maximum adsorption values (y (m)) were obtained from the simple Langmuir model. As compared with the iodide, the iodate was adsorbed in higher amounts by the soils tested. Among three soils, the REQ soil adsorbed more iodine (I(-) and IO (3) (-) ) than the IS and AS. The distribution coefficient (K (d)) of iodine in the soils decreased exponentially with increasing iodine loading concentration. Desorption of iodine in soil was increased correspondingly with increasing adsorption values. The REQ soil had a greater affinity for iodine than the IS and AS at the same iodine loadings. In the pot experiment cultivated with pakchoi (Brassica chinensis L.) and added with two exogenous iodine sources, the iodide form was quickly taken up by pakchoi and caused more toxicity to the vegetable. The rate of iodine loss from soil was higher for iodide form as compared with the iodate. The iodine bioavailability was the highest but the persistence was the weakest in AS among the three soils tested, and the REQ soil showed just the opposite trend to that of the AS soil. This study is of theoretical importance to understand the relationship between iodine adsorption-desorption characteristics and their bioavailability in different soils and it also has practical implications for seeking effective alternatives of iodine biofortification to prevent iodine deficiency disorders.


Asunto(s)
Silicatos de Aluminio/química , Yodatos/química , Yoduros/química , Suelo/química , Adsorción , Algoritmos , Silicatos de Aluminio/metabolismo , Brassica/crecimiento & desarrollo , Brassica/metabolismo , Arcilla , Concentración de Iones de Hidrógeno , Yodatos/metabolismo , Yodatos/farmacocinética , Yoduros/metabolismo , Yoduros/farmacocinética , Cinética , Modelos Químicos , Termodinámica
4.
J Sci Food Agric ; 90(5): 906-13, 2010 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-20355129

RESUMEN

BACKGROUND: Iodine is an essential trace element for humans. Two billion individuals have insufficient iodine intake. Biofortification of vegetables with iodine offers an excellent opportunity to increase iodine intake by humans. The main aim was to study the effect of iodine form and concentration in the nutrient solution on growth, development and iodine uptake of lettuce, grown in water culture. RESULTS: In both a winter and summer trial, dose rates of 0, 13, 39, 65, and 90 or 129 microg iodine L(-1), applied as iodate (IO(3)(-)) or iodide (I(-)), did not affect plant biomass, produce quality or water uptake. Increases in iodine concentration significantly enhanced iodine content in the plant. Iodine contents in plant tissue were up to five times higher with I(-) than with IO(3)(-). Iodine was mainly distributed to the outer leaves. The highest iodide dose rates in both trials resulted in 653 and 764 microg iodine kg(-1) total leaf fresh weight. CONCLUSION: Biofortification of lettuce with iodine is easily applicable in a hydroponic growing system, both with I(-) and IO(3)(-). I(-) was more effective than IO(3)(-). Fifty grams of iodine-biofortified lettuce would provide, respectively, 22% and 25% of the recommended daily allowance of iodine for adolescents and adults.


Asunto(s)
Alimentos Fortificados , Yodo/química , Yodo/farmacocinética , Lactuca/crecimiento & desarrollo , Lactuca/metabolismo , Biomasa , Productos Agrícolas , Enfermedades Carenciales/prevención & control , Conductividad Eléctrica , Alimentos Fortificados/análisis , Concentración de Iones de Hidrógeno , Hidroponía/métodos , Yodatos/farmacocinética , Yodo/deficiencia , Concentración Osmolar , Hojas de la Planta/química , Compuestos de Potasio/farmacocinética , Yoduro de Potasio/farmacocinética , Control de Calidad , Estaciones del Año , Factores de Tiempo , Distribución Tisular , Agua/análisis
5.
Thyroid ; 11(5): 449-56, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11396703

RESUMEN

Because it is more stable than iodide, most health authorities preferentially recommend iodate as an additive to salt for correcting iodine deficiency. Even though this results in a low exposure of at most 1,700 microg/d, doubts have recently been raised whether the safety of iodate has been adequately documented. In humans and rats, oral bioavailability of iodine from iodate is virtually equivalent to that from iodide. When given intravenously to rats, or when added to whole blood or tissue homogenates in vitro or to foodstuff, iodate is quantitatively reduced to iodide by nonenzymatic reactions, and thus becomes available to the body as iodide. Therefore, except perhaps for the gastrointestinal mucosa, exposure of tissues to iodate might be minimal. At much higher doses given intravenously (i.e., above 10 mg/kg), iodate is highly toxic to the retina. Ocular toxicity in humans has occurred only after exposure to doses of 600 to 1,200 mg per individual. Oral exposures of several animal species to high doses, exceeding the human intake from fortified salt by orders of magnitude, pointed to corrosive effects in the gastrointestinal tract, hemolysis, nephrotoxicity, and hepatic injury. The studies do not meet current standards of toxicity testing, mostly because they lacked toxicokinetic data and did not separate iodate-specific effects from the effects of an overdose of any form of iodine. With regard to tissue injury, however, the data indicate a negligible risk of the small oral long-term doses achieved with iodate-fortified salt. Genotoxicity and carcinogenicity data for iodate are scarce or nonexisting. The proven genotoxic and carcinogenic effects of bromate raise the possibility of analogous activities of iodate. However, iodate has a lower oxidative potential than bromate, and it did not induce the formation of oxidized bases in DNA under conditions in which bromate did, and it may therefore present a lower genotoxic and carcinogenic hazard. This assumption needs experimental confirmation by proper genotoxicity and carcinogenicity data. These in turn will have to be related to toxicokinetic studies, which take into account the potential reduction of iodate to iodide in food, in the intestinal lumen or mucosa, or eventually during the liver passage.


Asunto(s)
Yodatos/envenenamiento , Carcinógenos , Aditivos Alimentarios , Humanos , Yodatos/administración & dosificación , Yodatos/química , Yodatos/farmacocinética , Yodo , Legislación Alimentaria , Mutágenos , Política Nutricional , Cloruro de Sodio Dietético , Estados Unidos
6.
Plant Soil ; 212(2): 135-43, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-11762382

RESUMEN

In the Xinjiang province of western China, conventional methods of iodine (I) supplementation (i.e, goiter pills and iodinated salt) used to mitigate I deficiencies were ineffectual. However, the recent addition of KIO3 to irrigation waters has proven effective. This study was conducted to determine the effects of I form and concentration on rice (Oryza sativa L.) growth, I partitioning within the plant, and ultimately to assist in establishing guidelines for incorporating I into the human food chain. We compared IO3- vs. I- in order to determine how these chemical species differ in their biological effects. Rice was grown in 48 L aerated tubs containing nutrient solution and IO3- or I- at 0, 1, 10, or 100 micromoles concentrations (approximately 0, 0.1, 1, and 10 mg kg-1 I). The IO3- at 1 and 10 micromoles had no effect on biomass yields, and the 100 micromole treatment had a small negative effect. The I- at 10 and 100 micromoles was detrimental to biomass yields. The IO3- treatments had more I partitioning to the roots (56%) on average than did the I- treatments (36%), suggesting differences in uptake or translocation between I forms. The data support the theory that IO3- is electrochemically or biologically reduced to I- prior to plant uptake. None of the treatments provided sufficient I in the seed to meet human dietary requirements. The I concentration found in straw at 100 micromoles IO3- was several times greater than seed, and could provide an indirect source of dietary I via livestock feeding on the straw.


Asunto(s)
Yodatos/farmacocinética , Yoduros/farmacocinética , Yodo/metabolismo , Oryza/metabolismo , Semillas/metabolismo , Biomasa , Medios de Cultivo/farmacocinética , Relación Dosis-Respuesta a Droga , Hidroponía , Yodo/análisis , Valor Nutritivo , Oryza/crecimiento & desarrollo , Raíces de Plantas/crecimiento & desarrollo , Raíces de Plantas/metabolismo , Semillas/crecimiento & desarrollo , Agua/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...